Novacyt S.A. (ALNOV.PA)

EUR 0.45

(-2.68%)

Long Term Debt Summary of Novacyt S.A.

  • Novacyt S.A.'s latest annual long term debt in 2023 was 12.49 Million GBP , up 4650.95% from previous year.
  • Novacyt S.A.'s latest quarterly long term debt in 2023 FY was 12.49 Million GBP , up 4650.95% from previous quarter.
  • Novacyt S.A. reported annual long term debt of 263 Thousand GBP in 2022, down -81.81% from previous year.
  • Novacyt S.A. reported annual long term debt of 1.44 Million GBP in 2021, down -26.37% from previous year.
  • Novacyt S.A. reported quarterly long term debt of 249.07 Thousand GBP for 2023 Q1, down -5.3% from previous quarter.
  • Novacyt S.A. reported quarterly long term debt of 219 Thousand GBP for 2023 Q2, down -12.07% from previous quarter.

Annual Long Term Debt Chart of Novacyt S.A. (2023 - 2011)

Historical Annual Long Term Debt of Novacyt S.A. (2023 - 2011)

Year Long Term Debt Long Term Debt Growth
2023 12.49 Million GBP 4650.95%
2022 263 Thousand GBP -81.81%
2021 1.44 Million GBP -26.37%
2020 1.96 Million GBP -75.38%
2019 7.97 Million EUR 291.66%
2018 2.03 Million EUR 105.74%
2017 989.83 Thousand EUR -57.87%
2016 2.34 Million EUR 51.37%
2015 1.55 Million EUR 210.38%
2014 500 Thousand EUR 9.82%
2013 455.28 Thousand EUR -9.85%
2012 505.03 Thousand EUR -41.02%
2011 856.3 Thousand EUR 0.0%

Peer Long Term Debt Comparison of Novacyt S.A.

Name Long Term Debt Long Term Debt Difference
Affluent Medical SA 14.41 Million EUR 13.295%
Bluelinea Société Anonyme 2.11 Million EUR -491.995%
Carmat SA 57.64 Million EUR 78.326%
Diagnostic Medical Systems S.A. 13.19 Million EUR 5.327%
Euromedis Groupe 5.08 Million EUR -145.67%
Eurobio Scientific Société anonyme 81.23 Million EUR 84.618%
Ikonisys S.A. 3.2 Million EUR -289.556%
Implanet S.A. 1.38 Million EUR -804.124%
Median Technologies SA 21.64 Million EUR 42.26%
SpineGuard SA 1.87 Million EUR -566.167%
Theraclion SA 1.95 Million EUR -540.527%
Euroapi S.A. 15.5 Million EUR 19.387%
Guerbet SA 360.51 Million EUR 96.534%